Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Seaport Therapeutics, Inc. | 863,031 | reported | 04 May 2026 | tx 4+1,070,481−210,526 |
| ELI LILLY & Co | 56,249 | reported | 01 Feb 2010 | tx 69+650,531−497,406 |
| Rapport Therapeutics, Inc. | 41,666 | reported | 12 Sept 2025 | tx 3+63,516 |
| Voyager Therapeutics, Inc. | 15,000 | reported | 03 Jun 2021 | tx 7+605,000 |
| Sage Therapeutics, Inc. | 3,971 | reported | 03 Jan 2024 | tx 79+731,009−916,158 |
| ALNYLAM PHARMACEUTICALS, INC. | 2,526 | reported | 01 Apr 2022 | tx 32+214,751−120,000 |
| Karuna Therapeutics, Inc. | 0 | reported | 18 Mar 2024 | tx 54+1,711,198−5,158,780 |
| SIGMA ALDRICH CORP | 0 | reported | 18 Nov 2015 | tx 37+95,142−91,542 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 May 2026 | CONVERSION | Seaport Therapeutics, Inc. | 67,031 | — | |
| 30 Apr 2026 | GRANT_AWARD | Seaport Therapeutics, Inc. | 12,258 | 0.00 USD | deriv |
| 30 Apr 2026 | GRANT_AWARD | Seaport Therapeutics, Inc. | 991,192 | 0.00 USD | deriv |
| 04 May 2026 | CONVERSION | Seaport Therapeutics, Inc. | 210,526 | 0.00 USD | deriv |
| 12 Sept 2025 | PURCHASE | Rapport Therapeutics, Inc. | 28,284 | 24.50 USD | |
| 12 Sept 2025 | PURCHASE | Rapport Therapeutics, Inc. | 13,382 | 24.97 USD | first after silence |
| 17 Jun 2025 | GRANT_AWARD | Rapport Therapeutics, Inc. | 21,850 | 0.00 USD | deriv |
| 18 Mar 2024 | OTHER | Karuna Therapeutics, Inc. | 2,046 | 330.00 USD | |
| 18 Mar 2024 | OTHER | Karuna Therapeutics, Inc. | 35,877 | 330.00 USD | |
| 18 Mar 2024 | OTHER | Karuna Therapeutics, Inc. | 30,304 | 330.00 USD | |
| 18 Mar 2024 | OTHER | Karuna Therapeutics, Inc. | 33,882 | 330.00 USD | |
| 18 Mar 2024 | OTHER | Karuna Therapeutics, Inc. | 10,000 | 330.00 USD | |
| 18 Mar 2024 | OTHER | Karuna Therapeutics, Inc. | 30,304 | 330.00 USD | |
| 18 Mar 2024 | OTHER | Karuna Therapeutics, Inc. | 8,550 | 330.00 USD | |
| 18 Mar 2024 | OTHER | Karuna Therapeutics, Inc. | 22,800 | 142.74 USD | deriv |
| 18 Mar 2024 | OTHER | Karuna Therapeutics, Inc. | 146,900 | 218.03 USD | deriv |
| 18 Mar 2024 | OTHER | Karuna Therapeutics, Inc. | 161,850 | 198.36 USD | deriv |
| 18 Mar 2024 | OTHER | Karuna Therapeutics, Inc. | 135,992 | 230.28 USD | deriv |
| 18 Mar 2024 | OTHER | Karuna Therapeutics, Inc. | 71,121 | 309.98 USD | deriv |
| 18 Mar 2024 | OTHER | Karuna Therapeutics, Inc. | 15,205 | 320.80 USD | deriv |
| 18 Mar 2024 | OTHER | Karuna Therapeutics, Inc. | 87,494 | 320.80 USD | deriv |
| 18 Mar 2024 | OTHER | Karuna Therapeutics, Inc. | 449,463 | 320.80 USD | deriv |
| 18 Mar 2024 | OTHER | Karuna Therapeutics, Inc. | 757,045 | 322.73 USD | deriv |
| 18 Mar 2024 | OTHER | Karuna Therapeutics, Inc. | 136,094 | 322.96 USD | deriv |
| 18 Mar 2024 | OTHER | Karuna Therapeutics, Inc. | 616,703 | 314.00 USD | deriv |
3 purchases reported after at least 12 months of silence — most recent on 12 Sept 2025.